| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Jan 25 | URGN UroGen Pharma | RSU Ordinary Shares | Grant | Acquire A | No | No | 0 | 96,377 | 0.00 | 96,377 |
| 5 Jun 24 | ALLO Allogene Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.44 | 191,082 | 466.24 k | 191,082 |
| 31 Jan 24 | URGN UroGen Pharma | RSU Ordinary Shares | Grant | Acquire A | No | No | 0 | 87,615 | 0.00 | 87,615 |
